Summary
Careful, lower urinary tract localization studies have to be used to classify patients in the chronic bacterial prostatitis group and others. Considerable progress has been made in understanding the pathophysiology and developing rational approaches for treatment of patients with chronic bacterial prostatitis. Ciprofloxacin is a new quinolone carboxylic acid derivate with marked activity against both gram-negative and gram-positive bacteria. A critical analysis of the most recent achievements in the area of chronic bacterial prostatitis is presented.
Zusammenfassung
Die Abgrenzung der chronischen bakteriellen Prostatitis gegenüber anderen Krankheiten erfolgt durch sorgfältige Untersuchungen zur Lokalisation der Infektion in den unteren Harnwegen. In der Aufklärung der Pathophysiologie der chronischen bakteriellen Prostatitis und Entwicklung rationaler Therapien wurden erhebliche Fortschritte gemacht. Ciprofloxacin ist ein neues Carboxylsäure-Chinolon das hohe Aktivität gegen gramnegative wie grampositive Bakterien besitzt. Die neuesten Errungenschaften auf dem Gebiet der chronischen bakteriellen Prostatitis werden einer kritischen Analyse unterzogen.
Similar content being viewed by others
References
Meares, E. M., Stamey, T. A. Bacteriologic localization patterns in bacterial prostatitis and urthritis. Invest. Urol. 5 (1968) 492–518.
Drach, G. W., Meares, E. M., Fair, W. R., Stamey, T. A. Classification of benign disease associated with prostatic pain: Prostatitis or prostatodynia? J. Urol. 120 (1978) 266.
Baert, L., Leonard, A. Chronic bacterial prostatitis: 10 years of experience with local antibiotics. J. Urol. 140 (1988) 755–757.
Stamey, T. A.: Urinary Infections. The Williams & Wilkins Company, 1968, pp. 187–199.
Stamey, T. A., Meares, E. M. Jr., Winningham, D. G. Chronic bacterial prostatitis and the diffusion of drugs into prostatic fluid. J. Urol. 103 (1970) 187–194.
Baumueller, A., Madsen, P. O. Experimental bacterial prostatitis in dogs. Urol. Res. 5 (1977) 215–218.
Baert, L., Soep, H., Pyck, J. Chronische bacteriële prostatitis: een nieuwe behandelingsmethode: in loco antibiotherapie. Tijdschrift voor Geneeskunde 16 (1975) 794–804.
Fair, W. R., Couch, J., Welner, N. Prostatic antibacterial factor. Identity and significance. Urology 7 (1976) 169–177.
Meares, E. M. Chronic bacterial prostatitis: Role of transurethral prostatectomy (TURP) in therapy: In:Weidner, W., Brunner, H., Krause, W., Rothauge, C. F. (eds.): Therapy of prostatitis. Zuckschwerdt Verlag, München, Bern, Wien, San Francisco 1986, pp. 193–197.
Pfau, A. The treatment of chronic bacterial prostatitis. In:Weidner, W., Brunner, H., Krause, W., Rothauge, C. F. (eds.): Therapy of prostatitis. Zuckschwerdt Verlag, München, Bern, Wien, San Francisco 1986, pp. 27–30.
Weidner, W., Schieffer, H. G. Treatment of chronic bacterial prostatitis with ciprofloxacin. Results of a one-year follow-up study. Amer. J. of Med. 82 (1987) 280–283.
Baert, L., Leonard, A., D'Hoedt, M., Vandeursen, R. Seminal vesiculography in chronic bacterial prostatitis. J. Urol. 136 (1986) 844–845.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Baert, L., Van Poppel, H. & Vandeursen, H. Review of modern trends in the treatment of chronic bacterial prostatitis (C. B. P.). Infection 19 (Suppl 3), S157–S159 (1991). https://doi.org/10.1007/BF01643688
Issue Date:
DOI: https://doi.org/10.1007/BF01643688